The Peptide ERα17p Is a GPER Inverse Agonist that Exerts Antiproliferative Effects in Breast Cancer Cells

The inhibition of the G protein-coupled estrogen receptor (GPER) offers promising perspectives for the treatment of breast tumors. A peptide corresponding to part of the hinge region/AF2 domain of the human estrogen receptor α (ERα17p, residues 295–311) exerts anti-proliferative effects in various b...

Descripción completa

Detalles Bibliográficos
Autores principales: Lappano, Rosamaria, Mallet, Christophe, Rizzuti, Bruno, Grande, Fedora, Galli, Giulia Raffaella, Byrne, Cillian, Broutin, Isabelle, Boudieu, Ludivine, Eschalier, Alain, Jacquot, Yves, Maggiolini, Marcello
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627388/
https://www.ncbi.nlm.nih.gov/pubmed/31207943
http://dx.doi.org/10.3390/cells8060590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627388/
https://www.ncbi.nlm.nih.gov/pubmed/31207943
http://dx.doi.org/10.3390/cells8060590

Ejemplares similares